Table 3 The HRD prevalence in different breast cancer subtypes

From: Homologous recombination deficiency among patients with germline or somatic non-BRCA1/2 homologous recombination repair gene variations

BC subtype

HRD+

HRD−

p

TNBC

8

15

0.0614

non-TNBC

6

36

 

HER2+

0

8

0.1848

HER2−

14

43

 

Total

14

65

 
  1. HRD homologous recombination deficiency, TNBC triple-negative breast cancer.
Back to article page